Illinois Federal Court Considers Whether Plaintiff Expert’s Methodologies Were Sufficiently Reliable under Daubert in a Pharmaceutical Case

September 14, 2015
/
Expert Witness
/

GlaxoSmithKline has attempted to knock out the plaintiff’s experts in Dolin v. GlaxoSmithKline, in its latest round of Daubert motions. Wendy Dolin is suing GSK after the suicide death of her prominent lawyer husband, who had been taking the generic form of Paxil, paroxetine, an antidepressant. This case made national news just a year ago when Judge Zagel of the Northern District of Illinois held that GSK could be liable for Dolin’s death under a negligence theory, not a product liability theory, even though…
Continue reading...

This Week’s Life Science Headlines

February 28, 2014
/
Design Defect FDA Litigation Medical Device News Pharmaceuticals Product Liability Recalls Regulatory
/

Life Science Matters

Litigation

J&J, Ethicon Sued Over Surgical Stapler Misfire (subscription required)
GSK Can’t Shake Calif. County’s Avandia False Ad Claims (subscription required)
Pradaxa Lawsuits Raise Questions Over Clinical Trial Data Accuracy
Firms Kick Off Benicar Diarrhea Suits Against Daiichi (subscription required)
Mirena Birth Control Lawsuit Filings Approach 1,000 Cases
Boston Scientific Obtryx Sling Lawsuits Consolidated for Trial
Zoloft False Ad Suit Time-Barred, Judge Finds (subscription required)
J&J Hid Topamax Birth Defect Risks, Philly Jury Hears (subscription required)
Total, Endo Units Hit With

Last Week’s Important Life Science Headlines

February 25, 2014
/
Class Action Design Defect FDA Litigation Medical Device News Pharmaceuticals Product Liability Recalls Regulatory
/

Life Science Matters

Litigation

Xarelto Lawsuit Filed Over Uncontrollable Internal Bleeding
Neomedic Cases Added to Vaginal Mesh Litigation in W.Va. Federal Court
Endo Puts Aside $520M for Vaginal Mesh Litigation (subscription required)
9^th Circ. Refuses to Revive Novartis Jaw Injury Litigation (subscription required)
FTC Bags $2M False Ad Win Against Diabetes Supplement Co. (subscription required)
J&J Mesh Suits Belong in Federal Court, 10^th Circ. Told (subscription required)
New Philly Mass Tort Program Created for Pelvic Mesh Suits (subscription required)
J&J Wins 1

This Week’s Science Headlines

January 31, 2014
/
Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Product Liability Regulatory
/

Life Science Matters

Litigation

Byetta Thyroid Cancer Lawsuit Centralization Request Filed with JPML
MDL Arguments Over Centralization of Lipitor Diabetes Cases Postponed
Top DOJ Atty Outline Pharma Fraud Enforcement (subscription required)
Possible Sanctions for Takeda in Actos Bladder Cancer MDL (subscription required)
Hydroxycut False Ad Claims Must Be Clarified, Judge Says (subscription required)
GNC Hit with Suit Claiming Diet Pills Led to Liver Damage (subscription required)
J&J Beats $258M Risperdal Verdict in Split La. High Court (subscription required)
Calif. Court Reverses Preemption of Medtronic

Pennsylvania Superior Court Upholds Dismissal of Suit Claiming Paxil Caused Birth Defects

December 9, 2013
/
FDA Pharmaceuticals
/

admin

The Pennsylvania Superior Court recently upheld the trial court’s ruling in Thomas v. SmithKline Beecham Corp., 27 Pa.D.&C. 5^th 279 (Pa.Commw. Ct. 2012). Thomas dismissed plaintiff’s wrongful death and survival claims based on her use of the antidepressant drug Paxil during pregnancy as time barred. She ingested Paxil during her pregnancy and she was subsequently informed in 2001 that a fetal echocardiogram revealed that her fetus had congenital heart defects. Three days later she chose to undergo a therapeutic abortion at less than…
Continue reading...

This Week’s Life Science Headlines

December 6, 2013
/
Design Defect FDA Litigation Medical Device News Pharmaceuticals Product Liability Recalls Regulatory
/

Life Science Matters

Litigation

Pamlab Can’t Bar Virtus’ Marketing In Unfair Competition Row (subscription required)
Pa. Appeals Court Upholds GSK Win in Paxil Pregnancy Suit (subscription required)
J&J Asks Pa. Court to Keep Risperdal Docs Under Seal (subscription required)
Standing Issue Threatens 15 Zometa Suits in NJ (subscription required)
23andMe Hit with False Ad Suit Over DNA Tests (subscription required)
Diageo Shells Out $81M to Settle Aussie, NZ Thalidomide Suits (subscription required)
Generic-Reglan Suits Doomed by Catch-22, 6^th Circ. Says (subscription required)
J&J

This Week’s Life Science Headlines

December 1, 2013
/
Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Product Liability Recalls Regulatory Settlements
/

Life Science Matters

Litigation

Stryker Rejuvenate Lawsuits Filed by Nearly 1,000 Hip Patients Nationwide
Novartis Can’t Apply NJ Punitives Cap in 3 Zometa Suits (subscription required)
Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions (subscription required)
Gardasil Lawsuit Filed in France Over Side Effects of HPV Vaccine
Judge Backs Jury Finding in J&J Body Powder Cancer Suit (subscription required)
OxyElite Pro Class Action Filed Over False Advertising
First Zoloft Trial in Federal MDL for Birth Defect Lawsuits to Begin Nov. 2014
J&J Takes Innovative,

This Week’s Life Science Headlines

October 31, 2013
/
FDA Medical Device News Pharmaceuticals Recalls Regulatory Settlements Verdicts
/

Life Science Matters

Litigation

6^th Circ. Won’t Hear Appeal of Darvocet Suit Remand (subscription required)
Okla. Supreme Court Gives Harsh Take on Abortion Drug Law (subscription required)
Takeaways from McPhee v. DePuy’s Preemption Pronouncement (subscription required)
Canadian Court Won’t Shrink Paxil Birth Defect Class (subscription required)
Major Medical Device Manufacturer Agrees to Pay $13.2 Million to Settle Foreign Corrupt Practices Act (FCPA) Charges
Dow Seeks En Banc Review of Cancer Cluster Suit (subscription required)
Lumina Diet Supplement Class Action Stays in Fed. Court

GlaxoSmithKline Announces $229 Million Settlement of Avandia Lawsuits

Life Science Matters

British drugmaker GlaxoSmithKline (GSK) announced on July 25^th that it would pay $229 million to resolve lawsuits brought by eight U.S. states related to improper marketing of its diabetes drug Avandia (rosiglitazone). In a regulatory filing, GSK said the settlement was within provisions it had previously set aside for litigation, and also resolved claims brought by the Attorney General of Louisiana involving other GSK products. The announcement by GSK explained that the settlements had been undertaken in order to avoid lengthy trials, and did…
Continue reading...

Life Science Matters An inside look at the latest legal developments involving medical devices, pharmaceuticals, and more

Illinois Federal Court Considers Whether Plaintiff Expert’s Methodologies Were Sufficiently Reliable under Daubert in a Pharmaceutical Case

This Week’s Life Science Headlines

Last Week’s Important Life Science Headlines

This Week’s Science Headlines

Pennsylvania Superior Court Upholds Dismissal of Suit Claiming Paxil Caused Birth Defects

This Week’s Life Science Headlines

This Week’s Life Science Headlines

This Week’s Life Science Headlines

GlaxoSmithKline Announces $229 Million Settlement of Avandia Lawsuits

Multicounty Litigation Order in New Jersey Provides No Guidance to Practitioners June 23, 2021

New Multicounty Litigation Application in New Jersey June 8, 2021

Lack of Agreement to Arbitrate Dooms Bid to Compel Arbitration May 26, 2021

Mixed Bag in New Jersey Medical Device Preemption Opinion May 12, 2021

First Circuit Agrees Pharmacists Provide Services, Not Sell Goods April 27, 2021